スポンサーリンク
Biochemical Research Laboratories, Kanegafuchi Chemical Industry Co., Ltd. | 論文
- Effect of .ALPHA.-(3,5-di-tert-butyl-4-hydroxybenzylidene)-.GAMMA.-butyrolactone (KME-4), a new anti-inflammatory drug, on the established adjuvant arthritis in rats.
- Pharmacological properties of a new anti-inflammatory compound, .ALPHA.-(3,5-di-tert-butyl-4-hydroxybenzylidene)-.GAMMA.-butyrolactone (KME-4), and its inhibitory effects on prostaglandin synthetase and 5-lipoxygenase.
- Inhibition of polymorphonuclear leukocyte 5-lipoxygenase and platelet cyclooxygenase by .ALPHA.-(3,5-di-tert-butyl-4-hydroxybenzylidene)-.GAMMA.-butyrolactone (KME-4), a new anti-inflammatory drug.
- Synthesis of (S)-β-Blockers from (S)-5-Hydroxymethyl-3-tert butyl-2-oxazolidinone or (S)-5-Hydroxymethyl-3-isopropyl-2-oxazolidinone